Cognitively Healthy Centenarian Brains resist Tau Accumulation and exhibit lower APOE, early proteasome response and maintained β-oxidation

Read full text
Authors: Marc Hulsman, Andrea B. Ganz, Meng Zhang, Frank Koopmans, Li Ka Wan, Suzanne S. M. Miedema, Susan Karijn Rohde, Maruelle C. Luimes, Tjado H. J. Morrema, Annemieke J.M. Rozemüller, Philip Scheltens, Jeroen J.M. Hoozemans
+3 more M. Reinders, August Benjamin Smit, Henne H. Holstege
Cited by: 1
References: 84

Abstract

Abstract Brains from cognitively intact centenarians offer a unique window into mechanisms of neuroprotection. We quantified 3,448 proteins by LC–MS/MS in middle temporal gyrus (MTG) from 88 Alzheimer’s disease (AD) patients, 53 controls (50–99 years) and 49 centenarians (100+). After adjustment for cell type composition, Aβ abundance associated with only five proteins, revealing upregulation of HTRA1, LRP1 and NRXN1 as early AD-associated changes. Conversely, tau abundance associated with ∼20% of the quantified proteome, revealing GPRIN1 as the top tau-associated protein. One-third of centenarians had high Aβ abundance, often with Braak neurofibrillary tangle stages IV/V, yet all maintained low local tau abundance. Centenarians showed maintained proteostasis (low ubiquitin peptides, high proteasome components), high PCSK1 (prohormone maturation), high PFKFB2 (glycolysis regulation), mitochondria-coupled lipid β-oxidation and lower APOE levels. Together, these findings suggest a model of neuroprotection in which Aβ facilitates tau seeding, and where proteostatic and metabolic adaptations buffer against additional tau accumulation in centenarians.

Fields of Study & Subjects

Alzheimer's disease research and treatments Genetics Aging and Longevity in Model Organisms Genetic Neurodegenerative Diseases

Publication details

Journal / source
medRxiv
Publisher
openRxiv
Publication date
8 January 2026
Document type
Preprint